Zhiying Pan

1.1k total citations · 1 hit paper
27 papers, 805 citations indexed

About

Zhiying Pan is a scholar working on Immunology, Statistics and Probability and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zhiying Pan has authored 27 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 11 papers in Statistics and Probability and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zhiying Pan's work include Biosimilars and Bioanalytical Methods (10 papers), Statistical Methods in Clinical Trials (9 papers) and Statistical Methods and Bayesian Inference (4 papers). Zhiying Pan is often cited by papers focused on Biosimilars and Bioanalytical Methods (10 papers), Statistical Methods in Clinical Trials (9 papers) and Statistical Methods and Bayesian Inference (4 papers). Zhiying Pan collaborates with scholars based in United States, Germany and Japan. Zhiying Pan's co-authors include D. Y. Lin, Vladimir Hanes, Bruce Allen Bach, Cristian Villanueva, Krzysztof Składowski, Paolo Foa, Eric Winquist, Ірина Давиденко, Sylvie Rottey and Lisa Licitra and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Zhiying Pan

27 papers receiving 767 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

2013 314 citations Jan B. Vermorken, Ірина Давиденко et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiying Pan United States	14	260	207	167	162	119	27	805
Jesper Heldrup Sweden	27	285 1.1×	161 0.8×	227 1.4×	140 0.9×	12 0.1×	70	2.2k
Shama Virani United States	17	516 2.0×	218 1.1×	166 1.0×	164 1.0×	6 0.1×	41	1.2k
Mererid Evans United Kingdom	15	290 1.1×	387 1.9×	181 1.1×	260 1.6×	4 0.0×	40	1.0k
Michelle R. Iannacone United States	18	304 1.2×	27 0.1×	32 0.2×	64 0.4×	28 0.2×	22	891
Shuangshuang Fu United States	13	306 1.2×	78 0.4×	40 0.2×	26 0.2×	8 0.1×	40	898
Chantal Babb de Villiers South Africa	19	426 1.6×	18 0.1×	96 0.6×	188 1.2×	8 0.1×	39	1.4k
Steinar Thoresen Norway	30	980 3.8×	40 0.2×	310 1.9×	79 0.5×	12 0.1×	49	2.4k
Ned Powell United Kingdom	20	314 1.2×	696 3.4×	241 1.4×	44 0.3×	6 0.1×	43	1.5k
Máire A. Duggan Canada	31	719 2.8×	49 0.2×	342 2.0×	182 1.1×	11 0.1×	123	2.9k
Siddharth Sheth United States	16	260 1.0×	223 1.1×	117 0.7×	68 0.4×	2 0.0×	60	607

Countries citing papers authored by Zhiying Pan

Since Specialization

Citations

This map shows the geographic impact of Zhiying Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiying Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiying Pan more than expected).

Fields of papers citing papers by Zhiying Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiying Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiying Pan. The network helps show where Zhiying Pan may publish in the future.

Co-authorship network of co-authors of Zhiying Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiying Pan. A scholar is included among the top collaborators of Zhiying Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiying Pan. Zhiying Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Mingming, Daoyang Wang, Yanpei Wang, et al.. (2023). Longitudinal predictions between executive function and general and specific psychiatric problems in school-age children.. Developmental Psychology. 59(11). 2050–2064. 5 indexed citations

Pan, Zhiying, et al.. (2021). Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trials. Contemporary Clinical Trials. 110. 106559–106559. 4 indexed citations

Pan, Zhiying, et al.. (2021). Design and Analysis of a Biosimilar Bridging Study with a Prediction Interval-Based Consistency Test. Therapeutic Innovation & Regulatory Science. 55(4). 765–772. 1 indexed citations

Burmester, Gerd R, Edit Drescher, Paweł Hrycaj, et al.. (2020). Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis. Clinical Rheumatology. 39(11). 3341–3352. 13 indexed citations

Chen, Qingxia, Donglin Zeng, Yuanye Zhang, et al.. (2020). Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching. UNC Libraries. 1 indexed citations

Thatcher, Nicholas, Jerome H. Goldschmidt, Michael Thomas, et al.. (2019). Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study. Clinical Cancer Research. 25(7). 2088–2095. 43 indexed citations

Hanes, Vladimir, Vincent Chow, Zhiying Pan, & Richárd Márkus. (2018). A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects. Cancer Chemotherapy and Pharmacology. 82(5). 899–905. 16 indexed citations

Márkus, Richárd, Vincent Chow, Zhiying Pan, & Vladimir Hanes. (2017). A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men. Cancer Chemotherapy and Pharmacology. 80(4). 755–763. 36 indexed citations

Thatcher, Nick, Michael B. Thomas, Zhiying Pan, et al.. (2017). Clinical comparison of ABP 215 and bevacizumab in patients with NSCLC: Pharmacokinetic results and justification for extrapolation across bevacizumab indications.. Journal of Clinical Oncology. 35(15_suppl). 9050–9050. 2 indexed citations

10.

Thatcher, Nick, Michael B. Thomas, Luis Paz‐Ares, et al.. (2016). Randomized, double-blind, phase 3 study evaluating efficacy and safety of ABP 215 compared with bevacizumab in patients with non-squamous NSCLC.. Journal of Clinical Oncology. 34(15_suppl). 9095–9095. 13 indexed citations

11.

Liu, Xiaohua, Zhiying Pan, Diansan Su, et al.. (2015). Remifentanil Ameliorates Liver Ischemia-Reperfusion Injury Through Inhibition of Interleukin-18 Signaling. Transplantation. 99(10). 2109–2117. 30 indexed citations

12.

Vermorken, Jan B., Ірина Давиденко, Lisa Licitra, et al.. (2013). Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. The Lancet Oncology. 14(8). 697–710. 314 indexed citations breakdown →

13.

Zhang, Yuanye, Ming‐Hui Chen, Joseph G. Ibrahim, et al.. (2013). Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching. Lifetime Data Analysis. 20(1). 76–105. 19 indexed citations

14.

Zheng, Gang, Long Jiang Zhang, Yue Cao, et al.. (2013). Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study. Metabolic Brain Disease. 28(3). 463–471. 10 indexed citations

15.

Pan, Zhiying, et al.. (2012). Role of Retinal Glial Cell Glutamate Transporters in Retinal Ganglion Cell Survival Following Stimulation of NMDA Receptor. Current Eye Research. 37(3). 170–178. 24 indexed citations

16.

Pan, Zhiying, et al.. (2011). Longitudinal Changes in Anterior Chamber Configuration in Eyes With Open-Angle Glaucoma and Associated Factors. Journal of Glaucoma. 21(5). 296–301. 8 indexed citations

17.

Pan, Zhiying & D. Y. Lin. (2005). Goodness‐of‐Fit Methods for Generalized Linear Mixed Models. Biometrics. 61(4). 1000–1009. 80 indexed citations

18.

Eggleston, Elizabeth, et al.. (2000). Evaluation of a sexuality education program for young adolescents in Jamaica. Revista Panamericana de Salud Pública. 7(2). 102–112. 33 indexed citations

19.

Pan, Zhiying & Lawrence L. Kupper. (1999). Sample size determination for multiple comparison studies treating confidence interval width as random. Statistics in Medicine. 18(12). 1475–1488. 1 indexed citations

20.

Mauck, Christine, Marianne M. Callahan, Richard J. Stock, et al.. (1999). The effect of one injection of Depo-Provera® on the human vaginal epithelium and cervical ectopy. Contraception. 60(1). 15–24. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact